John, Sam E. http://orcid.org/0000-0003-3780-2210
Opie, Nicholas L.
Wong, Yan T.
Rind, Gil S.
Ronayne, Stephen M.
Gerboni, Giulia
Bauquier, Sebastien H.
O’Brien, Terence J.
May, Clive N.
Grayden, David B. http://orcid.org/0000-0002-5497-7234
Oxley, Thomas J.
Article History
Received: 7 September 2017
Accepted: 10 May 2018
First Online: 30 May 2018
Change Date: 27 November 2018
Change Type: Correction
Change Details: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Competing Interests
: Dr’s. Opie and Oxley are directors of Smarstent Pty Limited and Synchron Inc. Dr. Oxley and a company associated with Dr. Opie are shareholders of Synchron Inc. Dr. John, Mr. Rind and Mr. Ronayne hold share options in Synchron Inc. Dr. John, Mr. Rind and Mr. Ronayne are employed by SmartStent Pty. Ltd as well as the University of Melbourne. This work was performed under employment at the University of Melbourne. Dr John, Dr Opie, Dr Wong, Mr Rind, Mr Ronayne, Dr. O’Brien, Dr. May, Dr. Grayden, Dr Oxley are listed as inventors on published or submitted patents on stentrode design and/or application. A company associated with Dr. Opie receives a consulting fee from SmartStent. SmartStent did not contribute financially or in kind to the experiments and analyses described in this work. Medtronic PLC (Covidien), Minneapolis, MN provided Solitaire stentriever devices used in this study as a gift. Medtronic was not involved in developing the devices, performing the study or analysis and it did not provide financial contributions to this work. All work was performed under the funding sources mentioned below. No other authors have any financial ties to SmartStent Pty. Ltd.